Unlock full data on AI in Healthcare with our free Lite plan!
Sign Up and Get Free AccessAI in Healthcare companies globally
Last updated:
Companies in AI in Healthcare
There are 11,925 companies in AI in Healthcare which include Medidata, Verily, Recursion, HealthifyMe, GRAIL. 3,865 companies in AI in Healthcare are funded, with 1,298 having secured Series A funding. Till date, the sector has seen the creation of 33 Unicorns. United States has the most number of companies in AI in Healthcare (4,542), followed by India
(813), and then United Kingdom (788).
2025 has seen the creation of 47 AI in Healthcare companies. On average, the last 10 years have seen 945 new companies launched every year. Most number of AI in Healthcare startups have been founded by alumni from Stanford University, Massachusetts Institute of Technology and Harvard University.
Here is a List of top companies in AI in Healthcare
1. Medidata
AI-based clinical trial management software for researchers. It offers a platform for data analysis, research experiment protocol designing, trail planning, supply, clinical management, and data management among others. The company has developed products such as CATIA R2021x, 3DEXPERIENCE, ENOVIA, BIOVIA, and more which assist with the drug discovery process.
Key facts about Medidata
- Founded Year: 1999
- Location: New York City (United States)
- Stage: Acquired
- Total Funding till date: $21.5M
- Investors: TFS, Insight Partners and 11 Others
- Latest Funding Round: Unattributed, Nov 06, 2023
- Tracxn Score: 89/100 What is this?
- Competitors Rank: 1 of 311 Competitors
2. Verily
Provider of AI based suite solution for health management. It focuses on leveraging technology and data science to enhance healthcare outcomes. The technology makes it possible to safely access and analyse medical data, which is crucial for creating novel treatments. It also offers solutions such as chronic health management and hospital patient management solution. It also has devices including sensor based watchers, glucose monitoring miniaturized CGM, and others.
Key facts about Verily
- Founded Year: 2015
- Location: Dallas (United States)
- Stage: Late Stage
- Total Funding till date: $2.5B
- Investors: Silver Lake, Temasek and 3 Others
- Latest Funding Round: PE, Sep 30, 2022
- Tracxn Score: 83/100 What is this?
- Competitors Rank: 2 of 784 Competitors
3. Recursion
Key facts about Recursion
- Founded Year: 2013
- Location: United States
- Stage: Public
- Total Funding till date: $452M
- Investors: DCVC, Felicis Ventures and 45 Others
- Latest Funding Round: Post IPO, Jul 12, 2023, $50M
- Tracxn Score: 81/100 What is this?
- Competitors Rank: 6 of 4,201 Competitors
4. HealthifyMe
Provider of AI-powered personalized nutrition and fitness coaching. This service uses advanced meal tracking technology to analyze dietary intake and provide tailored dietary and workout recommendations. Users receive personalized guidance and support from an AI coach, offering insights and notifications to promote healthier lifestyle choices. The platform also provides on-demand access to health information and personalized insights based on individual health data.
Key facts about HealthifyMe
- Founded Year: 2012
- Location: Singapore (Singapore)
- Stage: Series C
- Total Funding till date: $145M
- Investors: Khosla Ventures, LeapFrog Investments and 56 Others
- Latest Funding Round: Series C, Oct 25, 2024, $20M
- Tracxn Score: 81/100 What is this?
- Competitors Rank: 2 of 989 Competitors
5. GRAIL
Developer of a screening platform for circulating tumor DNA to detect cancer. The company is developing a test called "Galleri" a pan-cancer screening test by measuring circulating nucleic acids in the blood. Its proprietary platform uses the ultra-deep sequencing technique to measure levels of circulating tumor DNA in the patient's blood.
Key facts about GRAIL
- Founded Year: 2016
- Location: Menlo Park (United States)
- Stage: Public
- Total Funding till date: $2B
- Investors: Arch Venture Partners, CPP Investments and 47 Others
- Latest Funding Round: Series D, Nov 27, 2019, $390M
- Tracxn Score: 80/100 What is this?
- Competitors Rank: 2 of 306 Competitors